Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2005 by University of British Columbia.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
University of British Columbia
ClinicalTrials.gov Identifier:
NCT00120978
First received: July 11, 2005
Last updated: May 8, 2006
Last verified: April 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2006
  Estimated Primary Completion Date: No date given
No publications provided by University of British Columbia

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):